NCT00225251View on ClinicalTrials.gov

Wellbutrin XL for Dysthymic Disorder

PHASE4CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

May 31, 2008

Study Completion Date

June 30, 2008

Conditions

Dysthymic Disorder

Interventions

DRUG

bupropion XL

Antidepressant medication

OTHER

Placebo

Placebo

Trial Locations (1)

10019

Mood Disorders Research Program, St. Luke's-Roosevelt Hospital Center, New York

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

St. Luke's-Roosevelt Hospital Center

OTHER